Results 21 to 30 of about 518,303 (373)
British Journal of Dermatology, 2020 Tralokinumab, a fully human monoclonal antibody, specifically neutralizes interleukin‐13, a key cytokine driving peripheral inflammation in atopic dermatitis (AD). In phase II studies, tralokinumab combined with topical corticosteroids provided early and
A. Wollenberg +21 more
semanticscholar +1 more source
Health Science Reports, 2021 Background Connexin 43 (Cx43) plays a central role in the inflammatory response and wound healing. Targeting Cx43 expression reduces inflammation in a variety of injuries.
Mandy L. L. Tan +5 more
doaj +1 more source
Prevalence and Incidence of Atopic Dermatitis: A Systematic Review
Acta Dermato-Venereologica, 2020 The primary objective of this study was to systematically review and analyse epidemiological studies of the prevalence and incidence of atopic dermatitis (AD) during childhood and adulthood, focusing on data from the 21st century.
Simon B A Bylund +3 more
semanticscholar +1 more source
Shrinkage estimation for dose-response modeling in phase II trials with multiple schedules [PDF]
Statistics in Biopharmaceutical Research, 2020, 2020 Recently, phase II trials with multiple schedules (frequency of administrations) have become more popular, for instance in the development of treatments for atopic dermatitis. If the relationship of the dose and response is described by a parametric model, a simplistic approach is to pool doses from different schedules.
arxiv +1 more source
Dermatology Reports, 2012 Methylmethacrylate was first reported in 1941 as a cause of contact dermatitis. Since then, occupational contact allergies to acrylates in dentistry, orthopedic surgery, printing industry and industry have been reported, but few reports are found in the ...
Paula Maio +4 more
doaj +1 more source
Granuloma caused by Acanthocheilonema spp. in a canine - case report [PDF]
Arquivo Brasileiro de Medicina Veterinária e Zootecnia, 2022 A canine patient, 13-year-old mixed breed male, 24kg, was seen at a private clinic in the city of Guayaquil, Ecuador. The main reason for consultation was the evaluation of a mass in the right knee and neck that had previously been cytologically ...
A.R.O. Palacios +7 more
doaj +1 more source
Diagnostic Features of Atopic Dermatitis
Acta Dermato-Venereologica, 1980 is missing.
J. Hanifin, G. Rajka
semanticscholar +1 more source
Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis
JAMA dermatology, 2020 This randomized clinical trial investigates the efficacy and safety of abrocitinib in adolescents and adults with moderate-to-severe atopic dermatitis.
J. Silverberg +10 more
semanticscholar +1 more source
Yeast fungi of the genus Malassezia in dermatological diseases in animals [PDF]
Науковий вісник ветеринарної медицини, 2021 The relevance of a comprehensive study of yeast fungi of the genus Malassezia and the development of modern methods for the diagnosis of diseases caused by small domestic animals. Infectious diseases of small domestic animals caused by yeasts have become
Arkhypenko A., Ushkalov V.
doaj +1 more source
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
New England Journal of Medicine, 2016 BACKGROUND Dupilumab, a human monoclonal antibody against interleukin-4 receptor alpha, inhibits signaling of interleukin-4 and interleukin-13, type 2 cytokines that may be important drivers of atopic or allergic diseases such as atopic dermatitis ...
E. Simpson +24 more
semanticscholar +1 more source